Measles: is a new vaccine approach needed?

Lancet Infect Dis. 2018 Oct;18(10):1060-1061. doi: 10.1016/S1473-3099(18)30543-7.

Authors

Cléa Melenotte¹, Christine Zandotti¹, Philippe Gautret², Philippe Parola², Didier Raoult³

Affiliations

¹ MEPHI, IRD, APHM, IHU-Méditerranée Infection, Aix-Marseille University, 13005 Marseille, France.
² VITROME, IRD, APHM, IHU-Méditerranée Infection, Aix-Marseille University, 13005 Marseille, France.
³ MEPHI, IRD, APHM, IHU-Méditerranée Infection, Aix-Marseille University, 13005 Marseille, France; VITROME, IRD, APHM, IHU-Méditerranée Infection, Aix-Marseille University, 13005 Marseille, France. Electronic address: didier.raoult@gmail.com.

PMID: 30303095
DOI: 10.1016/S1473-3099(18)30543-7

No abstract available

MeSH terms

Humans
Measles / epidemiology
Measles / prevention & control*
Measles Vaccine / immunology*
Vaccination

Substances

Measles Vaccine